Key result
Acute myocardial ischemia plays a major role in sudden cardiac death, and beta-blockers are more beneficial than pure antiarrhythmic drugs in the setting of acute myocardial infarction.
Why the study?
Do anti-ischemic therapies such as beta-blockers and coronary revascularization reduce ventricular arrhythmias and sudden cardiac death in patients with ischemic heart disease?
Do anti-ischemic therapies such as beta-blockers and coronary revascularization reduce ventricular arrhythmias and sudden cardiac death in patients with ischemic heart disease?
This review highlights the critical role of acute ischemia in triggering fatal ventricular arrhythmias and supports the use of beta-blockers over pure antiarrhythmics like lidocaine to improve survival.
Answers are grounded in this paper and cite their sources.
Supports beta-blocker preference over antiarrhythmics in acute MI; leaves open prospective confirmation of ischemia's causal role in sudden death.
Direct evidence from pathologic-anatomical studies in victims of sudden cardiac death has been given for acute ischemia (caused by either an acute thrombus, plaque fissuring or an organizing thrombus) to play a major role in the genesis of sudden cardiac death. Furthermore, indirect data on the effects of drugs in the setting of acute myocardial infarction have demonstrated that treating patients with beta-blocking agents is more beneficial than treating them with a pure anti-arrhythmic drug such as lidocaine. Whereas lidocaine, which also reduces the incidence of ventricular fibrillation in the setting of acute myocardial infarction, may produce an excess of mortality, beta-blockers reduce ventricular fibrillation and are associated with a prolonged survival. Further, indirect evidence on the role of ischemia in ventricular arrhythmias is given in patients with chronic ischemic heart disease by several studies on coronary revascularization and by studies on antiarrhythmic drugs versus beta-blockers in the same situation. In conclusion, there is clear evidence from studies of coronary revascularization and from studies on drug intervention in different patient populations with ischemic heart disease at risk for ventricular arrhythmias and/or for sudden cardiac death that ischemia plays an important role in the genesis of these arrhythmias.
No takes yet. Share an insight, caveat, or question.
Kuck et al. (1994) conducted a review in Myocardial ischemia and ventricular arrhythmias. Beta-blockers vs. Antiarrhythmic drugs (e.g., lidocaine) was evaluated. Acute myocardial ischemia plays a major role in sudden cardiac death, and beta-blockers are more beneficial than pure antiarrhythmic drugs in the setting of acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: